What does regulatory writing support actually cover?

Regulatory writing support spans documentation across the full submission lifecycle, including clinical, nonclinical, and CMC writing, submission leadership for IND, NDA, BLA, and MAA milestones, clinical disclosure and transparency, regulatory operations like eCTD publishing, safety and pharmacovigilance documentation, and document quality management.

When should a sponsor bring in regulatory writing support?

Data management focuses on collecting, cleaning, and organizing clinical trial data through database design and quality control, while biostatistics focuses on analyzing that data to answer the trial's scientific and regulatory questions.

We already write our documents in-house. Why would we need outside support?

SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) are industry-standard data structures required by regulatory agencies like the FDA. Formatting trial data into these standards is what makes a submission's data package usable and reviewable by regulators.

Can a sponsor get support for just part of the submission process, or does it need to be end-to-end?

FSP (Functional Service Provider) is a flexible staffing model where a sponsor engages dedicated biometrics experts, such as programmers or biostatisticians, to integrate directly into their team, rather than outsourcing an entire function. It's often used when a sponsor needs to scale specific expertise quickly without building out a full internal department.

How does Veristat handle global regulatory and disclosure requirements?

A DMC is an independent group that periodically reviews accumulating trial data, often unblinded, to monitor patient safety and trial integrity. It provides an added layer of oversight that helps protect patients while maintaining the statistical validity of the trial.

Founder-led Biotech

Focus on the Science. We'll Handle the Infrastructure.

You're building a pipeline that could change medicine. You shouldn't have to build an entire infrastructure to get there. We partner with you to fill critical scientific and operational gaps, from protocol design through biostatistics and beyond.

TALK TO AN EXPERT →

CRITICAL PATHWAY

Key milestones where Veristat drives success

IND Prep & Filing

Scientific strategy, dossier assembly and filing readiness.

Trial Protocol Design

Innovative statistical modeling and protocol optimization.

Regulatory Alignment

Coordinating scientific advice and authority interactions.

Clinical Execution

Complex site activation, patient recruitment, and trial monitoring.

For major milestones, we lead

IND, NDA, BLA, MAA, we coordinate so every workstream lands together, not in pieces.

It doesn't stop at filing

Global disclosure requirements, aggregate safety reporting, we stay in it.

INTEGRATED PARTNERSHIP MODEL

Integrated support from strategy through execution

Instead of standard hand-off CRO mechanics, Veristat functions as a direct extension of your scientific core. Our experts sit on your program committees, align with your venture timelines, and scale up or down dynamically as data reads out.

No administrative friction. One unified communication layer
Dynamic scaling tied to regulatory and fundraising milestones
IP protection and fully compliant, audit-ready environments

#hs_cos_wrapper_widget_1788832919116 .cp-faq__a { grid-template-rows: 1fr !important; } #hs_cos_wrapper_widget_1788832919116 .cp-faq__a[hidden] { display: grid !important; } #hs_cos_wrapper_widget_1788832919116 .cp-faq__a-inner { overflow: visible !important; }

Company

Careers

Strategy

Evidence

Delivery

Submission

Other Therapy Areas

Resources

Insights

Founder-led Biotech

Focus on the Science. We'll Handle the Infrastructure.

THE BIOTECH SPONSOR TENSION

Navigating the complex path alone is high-risk

Lean Internal Team

No Built Infrastructure

High-Consequence Decisions

CRITICAL PATHWAY